RESULTS OF TREATMENT OF CHOROIDAL MALIGNANT-MELANOMA WITH HIGH-DOSE-RATE SR-90 BRACHYTHERAPY - A RETROSPECTIVE STUDY OF 46 PATIENTS TREATEDBETWEEN 1983 AND 1995

Citation
L. Missotten et al., RESULTS OF TREATMENT OF CHOROIDAL MALIGNANT-MELANOMA WITH HIGH-DOSE-RATE SR-90 BRACHYTHERAPY - A RETROSPECTIVE STUDY OF 46 PATIENTS TREATEDBETWEEN 1983 AND 1995, Graefe's archive for clinical and experimental ophthalmology, 236(3), 1998, pp. 164-173
Citations number
25
Categorie Soggetti
Ophthalmology
ISSN journal
0721832X
Volume
236
Issue
3
Year of publication
1998
Pages
164 - 173
Database
ISI
SICI code
0721-832X(1998)236:3<164:ROTOCM>2.0.ZU;2-B
Abstract
Purpose: We review the results of treatment of small to medium-sized c horoidal malignant melanomas after high-dose-rate brachytherapy with a strontium-90 applicator. Methods: The applicator is positioned agains t the sclera using an afterloading technique. Brachytherapy is complet ed in a single session lasting 2-4 h with the patient under local anae sthesia. From September 1983 until March 1995, 46 eyes were treated in this way. Most tumours were 7-11 mm in diameter (range from 4.5-15 mm ) with a mean height of approximately 3 mm (range from 1.5-7 mm). Foll ow-up ranged from 6 months to 12 years (mean 49 months). Results: Thir ty of the 46 eyes had at the final evaluation a non-evolutive scar (20 of these after a single application, the others with some additional treatment). In 13 eyes the rumours were in involution but their comple te destruction was not yet certain, and 3 eyes were enucleated for loc al recurrence. Three patients developed systemic metastases. No radiog enic complications were noticed. Conclusion: Strontium-90 brachytherap y is a valuable and safe treatment technique for small to medium-sized choroidal malignant melanomas. In addition the use of a strontium-90 applicator is inexpensive thanks to this element's long half-life and the short application time.